Identifying best practices for testing tobacco product safety
Official title: Workshop series to identify, discuss and develop recommendations for the optimal generation and use of in vitro assay data for tobacco product regulation
Funded at Institute for in Vitro Sciences, INC. · NIH-10947081 · Data updated 2026-11-12
This study is bringing together experts to create helpful guidelines for testing the safety of tobacco products, like e-cigarettes and smokeless tobacco, so that everyone can better understand how these products impact our health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Institute for in Vitro Sciences, INC. NIH-funded |
| Lab location | 1 site (Gaithersburg, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $49,988 |
| NIH project number | 1R13FD008161-01 |
| Project ID | NIH-10947081 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals concerned about the health impacts of tobacco products and those interested in regulatory processes related to tobacco safety.
✕Less likely to help
Patients who do not use tobacco products or are not affected by tobacco-related health issues may not receive direct benefits from this research.
What this research studies
This research involves a series of workshops aimed at developing recommendations for the optimal generation and use of in vitro assay data related to tobacco products. Experts will gather to discuss and refine methods for evaluating the toxicity of various tobacco products, including electronic nicotine delivery systems (ENDS) and smokeless tobacco. The goal is to create standardized guidelines that can help regulatory bodies assess the safety of these products more effectively. By focusing on scientifically sound approaches, the workshops aim to improve the understanding of how tobacco products affect human health.
Why it matters
Potential benefit: If successful, this research could lead to improved safety assessments for tobacco products, ultimately protecting public health.
How similar studies have gone: Previous workshops and initiatives have successfully established guidelines for toxicological assessments in other areas, suggesting that this approach could yield valuable outcomes.
Where this research is happening
-
Institute for in Vitro Sciences, INC.
Gaithersburg, United States Active
Researchers
- Principal investigator: Curren, Rodger D — Institute for in Vitro Sciences, INC.
- Study coordinator: Curren, Rodger D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.